$665M
$1.31 Million
0.0% of portfolio
40,293
Q2 2025
Reduced 15.18%
$463M
$956,000
0.0% of portfolio
268,732
Q2 2025
Added 40.17%
$411M
$832,000
0.0% of portfolio
183,008
Q2 2025
Reduced 22.09%
$256M
$150,000
0.0% of portfolio
31,371
Q2 2025
Added 52.69%
$97B
$1.04 Million
0.0% of portfolio
47,534
Q2 2025
Added 28.87%
$2.23B
$6.2 Million
0.0% of portfolio
143,906
Q2 2025
Reduced 6.99%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 1.49%
$992M
$5.15 Million
0.0% of portfolio
81,300
Q2 2025
Added 82.4%
-
$0
0.0% of portfolio
-
Q2 2025
Added 29.0%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.77B
$1.5 Million
0.0% of portfolio
29,277
Q2 2025
Added 145.61%
Innovex International Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 27.79%
$4.29B
$21.7 Million
0.0% of portfolio
157,430
Q2 2025
Added 1.66%
$2B
$18.8 Million
0.0% of portfolio
223,763
Q2 2025
Reduced 10.45%
$753M
$2.82 Million
0.0% of portfolio
75,892
Q2 2025
Reduced 14.59%
$196M
$458,000
0.0% of portfolio
65,205
Q2 2025
Reduced 10.81%
$7.49B
$17.6 Million
0.0% of portfolio
97,351
Q2 2025
Reduced 18.04%
$1.36B
$14.8 Million
0.0% of portfolio
737,321
Q2 2025
Reduced 10.39%
$1.6B
$21.1 Million
0.0% of portfolio
382,133
Q2 2025
Added 40.54%
$242M
$238,000
0.0% of portfolio
29,230
Q2 2025
Reduced 25.88%
$35.3M
$139,000
0.0% of portfolio
76,583
Q2 2025
Added 6.84%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 8.63%
Integra Lifesciences Hldgs C
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 3.51%
-
$0
0.0% of portfolio
-
Q2 2025
Added 50.0%
$879M
$2.36 Million
0.0% of portfolio
251,576
Q2 2025
Added 46.97%
$1.3B
$1.1 Million
0.0% of portfolio
132,129
Q2 2025
Added 32.22%
$1.72B
$18.3 Million
0.0% of portfolio
874,992
Q2 2025
Reduced 10.17%
$4.33B
$18.3 Million
0.0% of portfolio
274,446
Q2 2025
Reduced 5.28%
$549M
$655,000
0.0% of portfolio
64,933
Q2 2025
Reduced 5.67%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
Added 246.67%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
Added 8.19%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
Added 4.47%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.4%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 28.93%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
Added 45.56%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q3 2024
Added 109.6%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 10.0%
$0
$2.18 Million
0.0% of portfolio
43,475
Q2 2025
New
$0
$18.2 Million
0.0% of portfolio
33,063
Q2 2025
Added 1,057.26%
$0
$451,000
0.0% of portfolio
34,605
Q2 2025
Reduced 8.57%
$399M
$1.62 Million
0.0% of portfolio
45,366
Q2 2025
Reduced 10.43%
$2.02B
$5.57 Million
0.0% of portfolio
203,347
Q2 2025
Reduced 15.04%
-
$0
0.0% of portfolio
-
Q2 2025
Added 269.55%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
Added 59.56%
Invesco Actively Managed Exc
-
$0
0.0% of portfolio
-
Q2 2025
New
$249M
$17.8 Million
0.0% of portfolio
2,269,716
Q2 2025
Reduced 3.95%
$0
$6.11 Million
0.0% of portfolio
1,607,777
Q2 2025
Added 24.46%
$0
$1.5 Million
0.0% of portfolio
163,951
Q2 2025
Added 11.5%
$0
$965,000
0.0% of portfolio
101,750
Q2 2025
Reduced 28.89%